[1]
|
Aglycone solanidine and solasodine derivatives: A natural approach towards cancer
Biomedicine & Pharmacotherapy,
2017
DOI:10.1016/j.biopha.2017.07.147
|
|
|
[2]
|
Solasodine, Solamargine and Mixtures of Solasodine Rhamnosides: Pathway to Expansive Clinical Anticancer Therapies
International Journal of Clinical Medicine,
2017
DOI:10.4236/ijcm.2017.812064
|
|
|
[3]
|
Aglycone solanidine and solasodine derivatives: A natural approach towards cancer
Biomedicine & Pharmacotherapy,
2017
DOI:10.1016/j.biopha.2017.07.147
|
|
|
[4]
|
Synthesis of the tetrasaccharide glycoside moiety of Solaradixine and rapid NMR-based structure verification using the program CASPER
Tetrahedron,
2016
DOI:10.1016/j.tet.2015.12.042
|
|
|
[5]
|
Treatment of Skin Cancer with a Selective Apoptotic-Inducing CuradermBEC5 Topical Cream Containing Solasodine Rhamnosides
International Journal of Clinical Medicine,
2015
DOI:10.4236/ijcm.2015.65042
|
|
|
[6]
|
Treatment of Non Melanoma Skin Cancers: An Intra-Comparison Study of CuradermBEC5 and Various Established Modalities
Journal of Cancer Therapy,
2015
DOI:10.4236/jct.2015.612114
|
|
|
[7]
|
Topical CuradermBEC5 Therapy for Periocular Nonmela-noma Skin Cancers: A Review of Clinical Outcomes
International Journal of Clinical Medicine,
2013
DOI:10.4236/ijcm.2013.45041
|
|
|
[8]
|
Solasodine Glycosides: A Topical Therapy for Actinic Keratosis. A Single-Blind, Randomized, Placebo-Controlled, Parallel Group Study with CuradermBEC5
Journal of Cancer Therapy,
2013
DOI:10.4236/jct.2013.42076
|
|
|
[9]
|
Drug therapy: Solamargine and other solasodine rhamnosyl glycosides as anticancer agents
Modern Chemotherapy,
2013
DOI:10.4236/mc.2013.22005
|
|
|
[10]
|
Intralesion and CuradermBEC5 Topical Combination Therapies of Solasodine Rhamnosyl Glycosides Derived from the Eggplant or Devil’s Apple Result in Rapid Removal of Large Skin Cancers. Methods of Treatment Compared
International Journal of Clinical Medicine,
2012
DOI:10.4236/ijcm.2012.32024
|
|
|
[11]
|
CuradermBEC5 for Skin Cancers, Is It? An Overview
Journal of Cancer Therapy,
2011
DOI:10.4236/jct.2011.25099
|
|
|